Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,242 | 484 | 94.8% |
| Travel and Lodging | $362.60 | 3 | 3.1% |
| Education | $250.09 | 5 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,223 | 92 | $0 (2024) |
| Janssen Biotech, Inc. | $1,217 | 56 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,209 | 75 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,033 | 41 | $0 (2024) |
| Enterra Medical, Inc. | $810.41 | 6 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $636.13 | 6 | $0 (2024) |
| Celgene Corporation | $483.80 | 31 | $0 (2024) |
| Daiichi Sankyo Inc. | $470.27 | 18 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $403.59 | 4 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $392.80 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,885 | 135 | ABBVIE INC. ($915.83) |
| 2023 | $3,426 | 155 | ABBVIE INC. ($716.78) |
| 2022 | $2,895 | 126 | ABBVIE INC. ($507.46) |
| 2021 | $1,650 | 76 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($398.20) |
All Payment Transactions
492 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: LIVER DISEASE | ||||||
| 12/18/2024 | Enterra Medical, Inc. | — | Food and Beverage | In-kind items and services | $20.80 | General |
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.55 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: GI | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/07/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Immunology | ||||||
| 10/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Enterra Medical, Inc. | — | Travel and Lodging | In-kind items and services | $113.05 | General |
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 356 | 368 | $81,661 | $26,310 |
| 2022 | 5 | 358 | 374 | $87,690 | $26,750 |
| 2021 | 3 | 385 | 402 | $103,580 | $37,307 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 148 | $32,116 | $11,028 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $27,224 | $8,031 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 95 | $14,060 | $4,901 | 34.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $5,694 | $1,788 | 31.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 17 | 17 | $2,567 | $562.36 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 156 | $33,835 | $10,782 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 102 | 102 | $33,864 | $9,565 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 59 | $8,732 | $3,289 | 37.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $8,541 | $2,378 | 27.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 18 | 18 | $2,718 | $736.02 | 27.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 162 | 162 | $53,784 | $17,618 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 190 | 202 | $44,172 | $17,330 | 39.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 38 | $5,624 | $2,359 | 41.9% |
About Jessica Roth
Jessica Roth is a Nurse Practitioner healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2018. The National Provider Identifier (NPI) number assigned to this provider is 1407327224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Roth has received a total of $11,855 in payments from pharmaceutical and medical device companies, with $3,885 received in 2024. These payments were reported across 492 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,242).
As a Medicare-enrolled provider, Roth has provided services to 1,099 Medicare beneficiaries, totaling 1,144 services with total Medicare billing of $90,367. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Fort Worth, TX
- Active Since 12/06/2018
- Last Updated 04/27/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407327224
Products in Payments
- STELARA (Biological) $1,452
- XIFAXAN (Drug) $1,006
- RINVOQ (Biological) $918.38
- ENTYVIO (Biological) $836.17
- ZEPOSIA (Drug) $833.04
- SKYRIZI (Biological) $770.97
- INJECTAFER (Drug) $470.27
- OCALIVA (Drug) $392.80
- DUPIXENT (Biological) $385.67
- Talicia (Drug) $283.87
- TREMFYA (Drug) $267.96
- IBSRELA (Drug) $236.46
- CREON (Drug) $231.13
- TRULANCE (Drug) $190.04
- HUMIRA (Biological) $168.82
- RENFLEXIS (Drug) $165.04
- DIFICID (Drug) $150.82
- GIMOTI (Drug) $147.16
- MONOFERRIC (Drug) $145.45
- Linzess (Drug) $140.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Fort Worth
Mrs. Jennifer West, Np, NP
Nurse Practitioner — Payments: $63,534
Deborah Stapel, N.p, N.P
Nurse Practitioner — Payments: $31,024
Kathryn Moreland, Np, NP
Nurse Practitioner — Payments: $11,350
Cynthia Roger, Rn Msn, RN MSN
Nurse Practitioner — Payments: $11,112
Rose Julian, Anp-C, ANP-C
Nurse Practitioner — Payments: $8,483
Carrie Platt, Arnp, ARNP
Nurse Practitioner — Payments: $8,246